Sweat may be another way to pass on hepatitis B infection during contact sports, suggests research published ahead of print in the British Journal of Sports Medicine. Hepatitis B virus attacks the liver and can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death.
The research team analyzed blood and sweat samples from 70 male Olympic wrestlers for evidence of hepatitis B infection (HBV). The wrestlers, who were all aged between 18 and 30, were all asked about injuries, as bloodborne infection is a common route of transmission. Over a third said they had had bleeding or weeping wounds during training and competition. And almost half said that they had had an episode of bleeding during other activities. None of the wrestlers had active HBV infection, as evidenced by a lack of antibodies to the virus; nevertheless, the virus itself was found in the blood of nine (13 percent), suggesting that they had hidden or occult infection, says the author. This is perfectly plausible, given that intense training temporarily suppresses a normal immune response, she says.
Eight (11 percent) also had particles of the virus present in their sweat, and levels of the virus found in the blood closely matched those found in the sweat. The findings prompt the author to suggest that sweat, like open wounds and mucous membranes, could be another way of transmitting the infection.
Some sporting bodies have ruled that HIV testing should be mandatory for all contact sport competitors, but no such recommendations have been made for HBV, says the author. Yet HBV is far more transmissible, because much higher levels of the virus are found in the blood and it is not as fragile as HIV, she says, calling for HBV testing and vaccination for all wrestlers at the start of their career.
Source: British Medical Journal
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.